Expression of ER/PR Receptor, Her-2/neu, Ki67 and p53 in Endometrial Carcinoma: Clinicopathological Implication and Prognostic Value

被引：0
|
作者：
V. B. Shivkumar
Manisha A. Atram
Nitin M. Gangane
机构：
[1] Mahatma Gandhi Institute of Medical Sciences (MGIMS),Department of Pathology
[2] Mahatma Gandhi Institute of Medical Sciences,undefined
来源：
Indian Journal of Gynecologic Oncology | 2020年 / 18卷
关键词：
Endometrial cancer; ER/PR expression; Her-2/neu status; p53; Ki67;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Expression of ER/PR Receptor, Her-2/neu, Ki67 and p53 in Endometrial Carcinoma: Clinicopathological Implication and Prognostic Value
    Shivkumar, V. B.
    Atram, Manisha A.
    Gangane, Nitin M.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 18 (03)
  • [2] EXPRESSION OF ER, PR AND HER-2/NEU IN ENDOMETRIAL CARCINOMA - A CLINICOPATHOLOGICAL STUDY
    Kaur, J.
    Suri, A.
    Kaur, M.
    Bal, M. S.
    Kaur, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1549 - 1549
  • [3] Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma
    Garcia-Velasco, Adelaida
    Mendiola, Cesar
    Sanchez-Munoz, Alfonso
    Ballestin, Claudio
    Colorner, Ramon
    Cortes-Funes, Hernan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (06): : 367 - 371
  • [4] Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma
    Adelaida García-Velasco
    César Mendiola
    Alfonso Sánchez-Muñoz
    Claudio Ballestín
    Ramón Colomer
    Hernán Cortés-Funes
    Clinical and Translational Oncology, 2008, 10
  • [5] Expression of ER, PR, and Her-2/neu in Endometrial Cancer: A Clinicopathological Study
    Srijaipracharoen, Sunamchok
    Tangjitgamol, Siriwan
    Tanvanich, Sujitra
    Manusirivithaya, Sumonmal
    Khunnarong, Jakkapan
    Thavaramara, Thaovalai
    Leelahakorn, Surawute
    Pataradool, Kamol
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (01) : 215 - 220
  • [6] Histopathology study and antigen p53, Ki67, Her-2/neu manifestation in colorectal cancer
    Khien Van Vu
    Cong Hong Vo
    Dung Tuan Trinh
    Dung Tuang Trinh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 318 - 318
  • [7] Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
    Peng, Jian-Heng
    Zhang, Xiang
    Song, Jun-Long
    Ran, Liang
    Luo, Rong
    Li, Hong-Yuan
    Wang, Yong-Hong
    MEDICINE, 2019, 98 (02)
  • [8] Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer
    Ferrandina, G
    Ranelletti, FO
    Gallotta, V
    Martinelli, E
    Zannoni, GF
    Gessi, M
    Scambia, G
    GYNECOLOGIC ONCOLOGY, 2005, 98 (03) : 383 - 389
  • [9] Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma
    Lin, Chen-Sung
    Chang, Shi-Chuan
    Ou, Liang-Hung
    Chen, Chien-Ming
    Hsieh, Sophie Swen-Wan
    Chung, Yu-Ping
    King, Kuang-Liang
    Lin, Shoei-Loong
    Wei, Yau-Huei
    ONCOLOGY REPORTS, 2015, 33 (06) : 2924 - 2934
  • [10] Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes
    Khande, Tejal Abasaheb
    Joshi, Avinash R.
    Khandeparkar, Siddhi Gaurish Sinai
    Kulkarni, Maithili M.
    Gogate, Bageshri P.
    Kakade, Aniket R.
    Sahu, Piyush D.
    Khillare, Chaitnya D.
    INDIAN JOURNAL OF CANCER, 2020, 57 (02) : 190 - 197
12345